IM
Isaac Manke
Partner at Acorn Bioventures
United States
Overview
Isaac Manke is a Partner at Acorn Bioventures, bringing extensive expertise in biotechnology, investment banking, and corporate development. With a PhD from Massachusetts Institute of Technology, he has made significant investments in companies like Q32 Bio and OnKure Therapeutics, contributing to their growth and success in the biotech sector.
Work Experience
Partner
2020 - Current
Acorn Bioventures is a private and small capitalization biotech, specialty pharma and medical device companies.
General Partner
2009 - 2019
New Leaf Venture Partners is a venture capital firm focused on investments in healthcare technology companies.
Biotechnology Research Associate
2007 - 2009
AllianceBernstein is a publicly traded global asset management firm, with approximately $735 billion in assets under management at March
Associate Analyst - Biotechnology Equity Research
2006 - 2007
DB Capital Ventures invests in early-stage and emerging growth businesses and is a venture capital firm based in New York.
Senior Analyst
2005 - 2006
Health Advances is a strategy consulting firm that specializes in the biotechnology, medical device and pharmaceutical industries.
Health Advances offers the healthcare industry with strategic consultancy services that are based on analytics and insights.
Education
PhD
2000 - 2005